Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Axsome Therapeutics Inc
Swot
Axsome Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Axsome Therapeutics Inc has 15 Strengths, 9 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(15)
Weakness
(9)
Opportunity
(2)
Threats
(1)
Others
(1)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Consistent Highest Return Stocks over Five Years
Strong Momentum: Price above short, medium and long term moving averages
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
MACD crossed above zero line previous end of day
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Increasing Revenue every Quarter for the past 4 Quarters
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Volume Shockers
High Volume, High Gain
Promoter decreasing their shareholding
Momentum Trap (DVM)
Companies with High Debt
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mutual Funds Decreased Shareholding in Past Month
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks